IOVS JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2005;46:2708-2715.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0921

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergman, P. B.
Right arrow Articles by Werther, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergman, P. B.
Right arrow Articles by Werther, G. A.

Expression of the IGF System in Normal and Diabetic Transgenic (mRen-2)27 Rat Eye

Philip B. Bergman,1 Christina J. Moravski,2 Stephanie R. Edmondson,1 Vincenzo C. Russo,1 Leon A. Bach,1,3 Jennifer L. Wilkinson-Berka,2 and George A. Werther1

1From the Centre for Hormone Research, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia; the 2Department of Physiology, University of Melbourne, Parkville, Australia; and the 3Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Australia.

PURPOSE. In the present study, a recently described model of diabetic eye disease was used to investigate the distribution of the insulin-like growth factor (IGF) system in the eyes of transgenic (mRen-2)27 rats (exhibiting hypertension and elevated serum and ocular renin levels) with streptozotocin-induced diabetes.

METHODS. Female transgenic (mRen-2)27 rats were randomized to receive either streptozotocin (diabetic) or citrate buffer (control). After 10 months, the rats were killed and the eyes fixed and embedded in paraffin. In situ hybridization (ISH) was used to document the cellular distribution of mRNAs for components of the IGF system (IGF-I, IGF-I receptor [IGFIR] and IGF binding proteins [IGFBP]1 to -6) in the eyes.

RESULTS. In nondiabetic rats, mRNA for IGFBP-1, -5, and -6; IGF-I; and IGFIR were detected in the retina. In addition, IGF-I mRNA was present in the cornea, IGFBP-1 mRNA was observed in the cornea and iris, and IGFBP-5 and -6 mRNAs were identified in the ciliary body, iris, and cornea. mRNAs for IGFBP-2, -3, and -4 were not found in the eyes. In diabetic rats, reduced levels of IGFBP-6 mRNA were detectable, whereas levels of IGFBP-5 mRNA were increased in the inner and outer retina, rods and cones, iris, cornea, and ciliary body. Other components of the IGF system in the eye were unchanged with diabetes.

CONCLUSIONS. In the diabetic (mRen-2)27 rat, IGFBP-6 is downregulated and IGFBP-5 is upregulated by induction of diabetes. Because these IGFBPs may respectively have IGF-enhancing and IGF-inhibitory effects, these findings suggest a possible net IGF-enhancing effect induced by diabetes, providing further evidence for a role of the IGF system in the development of diabetic retinopathy.





This article has been cited by other articles:


Home page
IOVSHome page
C. Lofqvist, K. L. Willett, O. Aspegren, A. C. H. Smith, C. M. Aderman, K. M. Connor, J. Chen, A. Hellstrom, and L. E. H. Smith
Quantification and Localization of the IGF/Insulin System Expression in Retinal Blood Vessels and Neurons during Oxygen-Induced Retinopathy in Mice
Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1831 - 1837.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. Wong, L. Molyneaux, M. Constantino, S. M. Twigg, and D. K. Yue
Timing Is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors
Diabetes Care, October 1, 2008; 31(10): 1985 - 1990.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. T. Wang, N. J. Kunzevitzky, J. C. Dugas, M. Cameron, B. A. Barres, and J. L. Goldberg
Disease Gene Candidates Revealed by Expression Profiling of Retinal Ganglion Cell Development
J. Neurosci., August 8, 2007; 27(32): 8593 - 8603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology